Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
61
-
62por Wolf, Marc E., Luz, Beate, Niehaus, Ludwig, Bhogal, Pervinder, Bäzner, Hansjörg, Henkes, Hans“…On 29 January 2021, the European Medicines Agency (EMA) approved a COVID-19 vaccine developed by Oxford University and AstraZeneca (AZD1222, ChAdOx1 nCoV-19, COVID-19 vaccine AstraZeneca, Vaxzevria, Covishield). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
63por Vallée, A., Chan-Hew-Wai, A., Bonan, B., Lesprit, P., Parquin, F., Catherinot, É., Choucair, J., Billard, D., Amiel-Taieb, C., Camps, È., Cerf, C., Zucman, D., Fourn, E.“…CONCLUSIONS: On March 2021 many European countries suspended AstraZeneca vaccine for one week due to safety uncertainty. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
64por Barral, Matthias, Arrive, Lionel, El Mouhadi-Barnier, Sanaa, Cornelis, François H.Enlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
65
-
66“…A 26-year-old Iraqi male laboratory analyst with an unremarkable medical history presented with severe thrombocytopenia 2 days after receiving the Oxford-AstraZeneca coronavirus disease-2019 vaccine. The patient was asymptomatic with unremarkable examination findings. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
67“…Nearly all reported cases of post-COVID-19 vacciation inflammatory demyelinating polyneuropathy are linked to AstraZeneca vaccination and a variant with bifacial weakness is the most reported form of GBS globally.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
68Acute disseminated encephalomyelitis (ADEM) following recent Oxford/AstraZeneca COVID-19 vaccination“…This report describes the clinical context and autopsy findings in the first reported fatal case of acute disseminated encephalomyelitis (ADEM), developed after being vaccinated using the Oxford/AstraZeneca COVID-19 vaccine. ADEM is a rare autoimmune disease, causing demyelination in the brain and spinal cord. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
69
-
70por Lukaszuk, Krzysztof, Podolak, Amira, Malinowska, Paulina, Lukaszuk, Jakub, Jakiel, Grzegorz“…Media reports have caused a significant drop in confidence in the AstraZeneca ChAdOx1 nCoV-19 COVID-19 vector vaccine (Vaxzevria, AstraZeneca Södertälje, Sweden). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
71por Ibrahim Amer, Fatma Hamza, Alzayyat, Remah, Alzayyat, Nof, Alomran, Sarh, Wafai, Sumaya, Alabssi, Haila, Alsultan, Deem“…We disseminated the survey to 2293 individuals from May 2021 till September 2021 in the eastern province of Saudi Arabia, to males and females above the age of 18 who have been vaccinated by either Pfizer or AstraZeneca in one dose or two doses. Results: The most prevalent side effect was pain at the injection site (60.7%), followed by general fatigue (23.8%) and swelling at the injection site (16.7%), with shortness of breath being the least common (0.9%). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
72
-
73por Werda, S., El Matri, K., Kammoun, A., Chebil, A., Benzina, Z., Falfoul, Y., El Matri, L.Enlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
74por Haider, Taimur, Ali, Javeria, Ali, Syed Mushhood, Iftikhar, Aqsa Syed, Siddiqui, Ahsan Ali, Khan, Adeeba Salahuddin, Qamar, Javeria Ahmed, Sohail, Khadija, Anwar, Adnan, Hashmi, Atif A“…Therefore, this study aimed to assess the prevalence of Oxford/AstraZeneca vaccine side effects among participants. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
75“…With 17 million people having had the AstraZeneca vaccine, these are extremely rare events The EMA’s Pharmacovigilance Risk Assessment Committee (18 March 2021) concluded that the vaccine was safe, effective and the benefits outweighed the risks. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
76
-
77por Manus, Jean-MarieEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
78
-
79“…Vaccine-associated cerebral venous thrombosis has become an issue following the extensive vaccination program of the Coronavirus Disease of 2019 (COVID-19) Vaccine AstraZeneca (ChAdOx1 vaccine). The importance of early diagnosis should be emphasized due to the high mortality rate without appropriate treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
80por Introna, Alessandro, Caputo, Francesca, Santoro, Carlo, Guerra, Tommaso, Ucci, Maria, Mezzapesa, Domenico Maria, Trojano, Maria“…We report a case of Guillain-Barré syndrome (GBS) following the first dose of Oxford/AstraZeneca COVID-19 vaccine with papilledema as atypical onset. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto